Spruce Biosciences (Nasdaq: SPRB) has announced a new corporate strategy centered on the acquisition of tralesinidase alfa enzyme replacement therapy…
Read More

Spruce Biosciences (Nasdaq: SPRB) has announced a new corporate strategy centered on the acquisition of tralesinidase alfa enzyme replacement therapy…
Read More
The EU's Anti-Racism Strategy for 2026-2030, part of the Union of Equality framework, pursues three core objectives: strengthening enforcement of…
Read More